TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16597717

Group type: EXPERIMENTAL
Intervention: Cognitive strategy aiming for the neighboring clockwise target (45 degrees away)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implicit adaptation to the neighboring target
Number of subjects: 0
Study: 15357562

Group type: EXPERIMENTAL
Intervention: Intravenous administration (IV group, n = 25): ketamine 1 mg/kg and midazolam 0.05-0.1 mg/kg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Oral administration (PO group, n = 24): ketamine 3 mg/kg and midazolam 0.5 mg/kg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Rectal administration (PR group, n = 24): ketamine 3 mg/kg and midazolam 0.5 mg/kg
Number of subjects: 73
Study: 11128861

Group type: EXPERIMENTAL
Intervention: Female cohort
Number of subjects: 19

Group type: COMPARATOR
Intervention: Male cohort
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both cohorts
Number of subjects: 19
Study: 9344294

Group type: EXPERIMENTAL
Intervention: Parastep 1 ambulation system training (32 sessions)
Number of subjects: 16
Study: 1443450

Group type: EXPERIMENTAL
Intervention: terfenadine 60 mg daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: terfenadine 120 mg daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: terfenadine 180 mg daily
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: terfenadine (all doses)
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 2410979

Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 75

Group type: COMPARATOR
Intervention: TVP
Number of subjects: 75
Study: 30024215

Group type: EXPERIMENTAL
Intervention: Biobehavioral intervention (BBI) implemented by newly trained providers
Number of subjects: 158
Study: 29090982

Group type: EXPERIMENTAL
Intervention: High-Dose (HD) influenza vaccine (Fluzone® High-Dose)
Number of subjects: 2957

Group type: COMPARATOR
Intervention: Standard-Dose (SD) influenza vaccine (Fluzone®)
Number of subjects: 2957
Study: 26682921

Group type: EXPERIMENTAL
Intervention: Supervised mixed‐sex cardiac rehabilitation
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Supervised women‐only cardiac rehabilitation
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Home‐based cardiac rehabilitation
Number of subjects: 169

Group type: COMPARATOR
Intervention: Overall program adherence
Number of subjects: 169

Group type: COMPARATOR
Intervention: Functional capacity preprogram to postprogram
Number of subjects: 169
Study: 24249700

Group type: EXPERIMENTAL
Intervention: GBV-C viremia present
Number of subjects: 288

Group type: COMPARATOR
Intervention: No GBV-C viremia
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: GBV-C viremia
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: CD4 count <100/mm(3) with GBV-C
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: CD4 count
Number of subjects: 288
Study: 22194630

Group type: EXPERIMENTAL
Intervention: High-intensity intervention (n = 425)
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: Low-intensity intervention (n = 421)
Number of subjects: 1270

Group type: COMPARATOR
Intervention: Control group (n = 424)
Number of subjects: 1270

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1270
Study: 20042925

Group type: EXPERIMENTAL
Intervention: Intravenous rehydration
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral rehydration
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Oral and IV combined rehydration
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ad libitum rehydration
Number of subjects: 11

Group type: COMPARATOR
Intervention: All trials (IV, oral, oral and IV combined, ad libitum)
Number of subjects: 11
Study: 18005804

Group type: EXPERIMENTAL
Intervention: Music therapy for 45 minutes
Number of subjects: 66

Group type: COMPARATOR
Intervention: Uninterrupted rest period for 45 minutes
Number of subjects: 66
Study: 16076543

Group type: EXPERIMENTAL
Intervention: Intervention group received 2.5 days training on intercultural communication and patients were exposed to a videotaped instruction in the waiting room before consultation.
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Intervention group received 2.5 days training on intercultural communication.
Number of subjects: 162
Study: 12185428

Group type: EXPERIMENTAL
Intervention: High respiratory rate (30 breaths/min)
Number of subjects: 10
Study: 10687110

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg once a day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 41
Study: 8758156

Group type: EXPERIMENTAL
Intervention: Epidural morphine 0.5 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 11
Study: 1837744

Group type: EXPERIMENTAL
Intervention: Continuous treatment with 1600 micrograms salbutamol or 160 micrograms ipratropium bromide daily
Number of subjects: 223

Group type: COMPARATOR
Intervention: On demand treatment with salbutamol or ipratropium bromide during exacerbations or periods of dyspnoea
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Continuous treatment
Number of subjects: 223

Group type: COMPARATOR
Intervention: On demand treatment
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Salbutamol and ipratropium bromide
Number of subjects: 223
Study: 6785100

Group type: EXPERIMENTAL
Intervention: Indomethacin (75 mg/day for 3 days)
Number of subjects: 8
Study: 29218366

Group type: EXPERIMENTAL
Intervention: Haploidentical donor natural killer (NK) cell therapy with rituximab and IL‐2 (NK dose 0.5‐3.27 × 107 NK cells/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Haploidentical donor natural killer (NK) cell therapy
Number of subjects: 14
Study: 28528570

Group type: EXPERIMENTAL
Intervention: 5-week hypnosis intervention
Number of subjects: 172

Group type: COMPARATOR
Intervention: Structured attention counseling
Number of subjects: 172
Study: 26669859

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA) with continuous femoral nerve block (FNB)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sciatic nerve block (SNB) with continuous femoral nerve block (FNB)
Number of subjects: 34
Study: 23402476

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg) / Hydrochlorothiazide (HCTZ, 12.5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ARB + Calcium Channel Blocker (CCB)
Number of subjects: 0
Study: 21219118

Group type: EXPERIMENTAL
Intervention: 3D fluoroscopic navigated reaming
Number of subjects: 10

Group type: COMPARATOR
Intervention: Freehand group (control)
Number of subjects: 10
Study: 17920723

Group type: EXPERIMENTAL
Intervention: Thalidomide 100mg orally daily with carboplatin and etoposide every 3 weeks for 6 cycles, followed by maintenance thalidomide for up to 2 years
Number of subjects: 25
Study: 16549263

Group type: EXPERIMENTAL
Intervention: 3M-group (measurements at baseline, 2 and 6 months)
Number of subjects: 635

Group type: COMPARATOR
Intervention: 1M-group (measurements only at 6 months)
Number of subjects: 635
Study: 11914403

Group type: EXPERIMENTAL
Intervention: Current consulters (48% of migraine sufferers)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Lapsed consulters (21% of migraine sufferers)
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Overall migraine sufferers
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Current or lapsed consulters
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Overall migraine prevalence
Number of subjects: 568
Study: 9791750

Group type: EXPERIMENTAL
Intervention: BacT/Alert aerobic FAN bottle
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard anaerobic bottle
Number of subjects: 243
Study: 8541573

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Baseline conditions
Number of subjects: 30
Study: 2796346

Group type: EXPERIMENTAL
Intervention: Hydroxyurea plus pelvic irradiation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo plus pelvic irradiation
Number of subjects: 25
Study: 961726

Group type: EXPERIMENTAL
Intervention: Massed-demonstration trials with verbalization
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Massed trials without verbalization
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Distributed-demonstration trials with verbalization
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Distributed trials without verbalization
Number of subjects: 48
Study: 7027891

Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg Durules once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metoprolol 200 mg conventional tablets
Number of subjects: 20
Study: 30915647

Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient children
Number of subjects: 387

Group type: COMPARATOR
Intervention: Vitamin D insufficient children
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 387

Group type: COMPARATOR
Intervention: Total infections
Number of subjects: 387
Study: 30099417

Group type: EXPERIMENTAL
Intervention: Intubation tube of author's design with prophylactic tracheal sanation (vacuum aspiration and antiseptic irrigation every 3 hours), n = 50
Number of subjects: 90

Group type: COMPARATOR
Intervention: Classical non-cuff intubation tube without prophylactic tracheal sanation, n = 40
Number of subjects: 90
Study: 26975521

Group type: EXPERIMENTAL
Intervention: Intervention protocol implemented by care managers
Number of subjects: 76
Study: 25458326

Group type: EXPERIMENTAL
Intervention: Mobile phone based text message reminders on healthy lifestyle principles
Number of subjects: 537
Study: 21625252

Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 538

Group type: COMPARATOR
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 538
Study: 19170913

Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 121
Study: 17984409

Group type: EXPERIMENTAL
Intervention: Sustained-release bupropion hydrochloride, 150 mg/d
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Sustained-release bupropion hydrochloride, 300 mg/d
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study: 16231970

Group type: EXPERIMENTAL
Intervention: Male circumcision (intervention group)
Number of subjects: 3274

Group type: COMPARATOR
Intervention: Control group (circumcision offered at end of follow-up)
Number of subjects: 3274
Study: 11998988

Group type: EXPERIMENTAL
Intervention: Formoterol (6 microg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Terbutaline (500 microg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Formoterol (24 microg)
Number of subjects: 25
Study: 10447247

Group type: EXPERIMENTAL
Intervention: Advice to reduce fat and non-milk extrinsic (NME) sugar
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advice to reduce fat only, ad libitum sugar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no advice)
Number of subjects: 0
Study: 7788825

Group type: EXPERIMENTAL
Intervention: Intranasal meperidine (nasal group) - 27 mg per dose, self-administered, up to six puffs, with a minimum delay of 10 minutes between doses.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Subcutaneous meperidine injections (sc group) - 25 or 50 mg on request.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Both groups rated pain management as excellent or good.
Number of subjects: 44
Study: 2082312

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ketorolac 90 mg
Number of subjects: 125

Group type: COMPARATOR
Intervention: Meperidine 50 mg
Number of subjects: 125

Group type: COMPARATOR
Intervention: Meperidine 100 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg and 90 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Ketorolac and Meperidine
Number of subjects: 125
Study: 160266

Group type: EXPERIMENTAL
Intervention: Mobilisation and manipulation
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo physiotherapy
Number of subjects: 94
Study: 30690747

Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (n=21)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Cognitive defusion (n=22)
Number of subjects: 43
Study: 30508613

Group type: EXPERIMENTAL
Intervention: Food Parenting Inventory (FPI)
Number of subjects: 248
Study: 28070681

Group type: EXPERIMENTAL
Intervention: Balloon sacroplasty (BSP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Radiofrequency sacroplasty (RFS)
Number of subjects: 40
Study: 26330156

Group type: EXPERIMENTAL
Intervention: HFOV + VG
Number of subjects: 20

Group type: COMPARATOR
Intervention: HFOV alone
Number of subjects: 20
Study: 23646904

Group type: EXPERIMENTAL
Intervention: Eczema Education Programme (EEP)
Number of subjects: 257
Study: 21540326

Group type: EXPERIMENTAL
Intervention: Small class sizes (13-17 students)
Number of subjects: 11601

Group type: COMPARATOR
Intervention: Regular class sizes (22-25 students)
Number of subjects: 11601
Study: 19178487

Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel, 0.05%
Number of subjects: 58

Group type: COMPARATOR
Intervention: vehicle gel
Number of subjects: 58
Study: 17970230

Group type: EXPERIMENTAL
Intervention: Latex sensitization (specific IgE > 0.7 kU/I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Clinical reactions to latex (urticaria, conjunctivitis, angioedema, rhinitis, bronchial asthma)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Correlation with latex allergy
Number of subjects: 80
Study: 15020025

Group type: EXPERIMENTAL
Intervention: Antenatal recruitment and randomisation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Consent and randomisation conducted on admission in labour
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Staged recruitment and randomisation (two- or three-staged)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Various study designs
Number of subjects: 14
Study: 11749095

Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Outreach intervention
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: In-reach intervention
Number of subjects: 510

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 510
Study: 9468077

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study: 8124991

Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg orally)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Meperidine (1 mg/kg, subcutaneously)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (normal volunteers)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dialysis patients
Number of subjects: 16
Study: 2682898

Group type: EXPERIMENTAL
Intervention: De-Nol (tripotassium dicitrate bismuthate)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 60570

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (4 tablets daily for 6-14 days)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no antibacterial therapy)
Number of subjects: 21
Study: 31642726

Group type: EXPERIMENTAL
Intervention: Strength training program (10-minute program, 3 times weekly for 12 weeks) targeting quadriceps, hip abductor, and core muscle groups
Number of subjects: 720

Group type: COMPARATOR
Intervention: Observation group (no intervention)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Strength training program
Number of subjects: 720

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 720
Study: 29945625

Group type: EXPERIMENTAL
Intervention: GSH+L-citrulline
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: L-citrulline-malate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 75
Study: 28820516

Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 180
Study: 25616974

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) group
Number of subjects: 173

Group type: COMPARATOR
Intervention: Non-Diabetes Mellitus (non-DM) group
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Normoglycemic DM patients (n = 24)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Non-Diabetes Mellitus (non-DM) patients
Number of subjects: 173
Study: 24075613

Group type: EXPERIMENTAL
Intervention: PRGF-Endoret (3 injections on a weekly basis)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Durolane hyaluronic acid (1 single injection)
Number of subjects: 96
Study: 21438778

Group type: EXPERIMENTAL
Intervention: Exercise withdrawal
Number of subjects: 26

Group type: COMPARATOR
Intervention: Exercise maintenance
Number of subjects: 26
Study: 18243430

Group type: EXPERIMENTAL
Intervention: Mw vaccine (1st dose of 1x10(9) heat killed organisms, 2nd dose of 5x10(8) organisms after 6 months)
Number of subjects: 28948

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28948

Group type: EXPERIMENTAL
Intervention: Mw vaccine
Number of subjects: 28948

Group type: EXPERIMENTAL
Intervention: Mw vaccine with BCG scars
Number of subjects: 28948

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 28948
Study: 17249432

Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite (NaOCl)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Ferric sulfate (FeSO4)
Number of subjects: 23
Study: 12714708

Group type: EXPERIMENTAL
Intervention: Cognitive functioning assessment in patients with CAO and TIA
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cerebrovascular reserve capacity measured by transcranial Doppler ultrasound
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Metabolic ratios measured by 1H‐MR spectroscopy
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Presence of lactate in noninfarcted regions
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cognitive impairment correlation with CO2 reactivity and N-acetyl aspartate to creatine ratio
Number of subjects: 39
Study: 11071432

Group type: EXPERIMENTAL
Intervention: Early signs of infarct on CT
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Early signs of infarct of more than 1/3 of the MCA territory
Number of subjects: 260
Study: 8952816

Group type: EXPERIMENTAL
Intervention: Intravenous linsidomine 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Parenteral isosorbide dinitrate
Number of subjects: 0
Study: 1794814

Group type: EXPERIMENTAL
Intervention: Cut-off filter glasses
Number of subjects: 12

Group type: COMPARATOR
Intervention: No cut-off filter glasses (control)
Number of subjects: 12
Study: 6307516

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) at 3000 rad in ten fractions (PCI+)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Observation (PCI-)
Number of subjects: 172
Study: 31473130

Group type: EXPERIMENTAL
Intervention: Oral TXA regimen
Number of subjects: 53

Group type: COMPARATOR
Intervention: Combined topical/IV/oral TXA
Number of subjects: 53
Study: 29972742

Group type: EXPERIMENTAL
Intervention: Tecovirimat 600 mg twice daily for 14 days
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Tecovirimat 10 mg/kg for 14 days (monkeypox model)
Number of subjects: 449

Group type: EXPERIMENTAL
Intervention: Tecovirimat 40 mg/kg for 14 days (rabbitpox model)
Number of subjects: 449

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study: 28388647

Group type: EXPERIMENTAL
Intervention: Probiotic Saccharomyces boulardii for 12 weeks
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Probiotic Saccharomyces boulardii
Number of subjects: 44
Study: 25609006

Group type: EXPERIMENTAL
Intervention: Cisplatin plus bevacizumab (cisplatin: 40 mg/m2, bevacizumab: 300 mg, every 2 weeks for 6 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cisplatin only (control group, n=27, cisplatin: 40 mg/m2 every 2 weeks for 6 weeks)
Number of subjects: 58
Study: 24228532

Group type: EXPERIMENTAL
Intervention: Xiaozhi particles, integrated Taohong Siwu tang and Erchen tang
Number of subjects: 180

Group type: COMPARATOR
Intervention: Xuezhikang capsule
Number of subjects: 180
Study: 21906813

Group type: EXPERIMENTAL
Intervention: Ahmed‐FP7 valve implant
Number of subjects: 238

Group type: COMPARATOR
Intervention: Baerveldt‐350 implant
Number of subjects: 238
Study: 18926726

Group type: EXPERIMENTAL
Intervention: Intensive intervention group received three months of hormonal contraception and counseling by a community health nurse (CHN).
Number of subjects: 103

Group type: COMPARATOR
Intervention: Minimal intervention group received counseling by a CHN and advised to schedule an appointment at a family planning clinic.
Number of subjects: 103
Study: 17217210

Group type: EXPERIMENTAL
Intervention: EMLA 5% cream
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Benzocaine 18% gel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lignocaine 5% ointment
Number of subjects: 60
Study: 14624816

Group type: EXPERIMENTAL
Intervention: 7% carbon dioxide (CO2) gas inhalation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High math anxiety individuals
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 64
Study: 10760191

Group type: EXPERIMENTAL
Intervention: Advanced practice nurse interventions during transitional care
Number of subjects: 0
Study: 8633378

Group type: EXPERIMENTAL
Intervention: Calcium carbonate and alphacalcidol (group B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Disodium etidronate and calcium carbonate (group A)
Number of subjects: 48
Study: 7962386

Group type: EXPERIMENTAL
Intervention: Immuno-selected spermatozoa fraction
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control swim-up fraction
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both immuno-depleted and swim-up sperm populations
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Overall IVF performance
Number of subjects: 9